Vogt-Koyanagi-Harada Disease-Like Uveitis during Nivolumab (Anti-PD-1 Antibody) Treatment for Metastatic Cutaneous Malignant Melanoma

Nivolumab is an anti-programmed cell death protein 1 monoclonal antibody that is used to treat metastatic cutaneous malignant melanoma. Although bilateral uveitis has been reported as a side effect of nivolumab administration, there are few reports of Vogt-Koyanagi-Harada disease (VKH)-like uveitis....

Descripción completa

Detalles Bibliográficos
Autores principales: Obata, Shumpei, Saishin, Yoshitsugu, Teramura, Kazuya, Ohji, Masahito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6489058/
https://www.ncbi.nlm.nih.gov/pubmed/31097947
http://dx.doi.org/10.1159/000496682

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6489058/
https://www.ncbi.nlm.nih.gov/pubmed/31097947
http://dx.doi.org/10.1159/000496682

Ejemplares similares